Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Bosch

Showing results (281-290 of 364) with videos related to

Pageof 37
Sort By:
Hepatology (Baltimore, Md.)|April 9, 2008
Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trialJaime Bosch, Dominique Thabut, Agustín Albillos, et al.
Hepatology (Baltimore, Md.)|November 26, 2002
Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosisRafael Bañares, Eduardo Moitinho, Ana Matilla, et al.
Hepatology (Baltimore, Md.)|December 21, 2016
Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet studyAnnalisa Berzigotti, Agustín Albillos, Candid Villanueva, et al.
The New England Journal of Medicine|June 25, 2010
Early use of TIPS in patients with cirrhosis and variceal bleedingJuan Carlos García-Pagán, Karel Caca, Christophe Bureau, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 15, 2013
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control studyFilippo Schepis, Ranka Vukotic, Annalisa Berzigotti, et al.
Clinical Science (London, England : 1979)|April 24, 2014
A novel form of the human manganese superoxide dismutase protects rat and human livers undergoing ischaemia and reperfusion injuryDiana Hide, Martí Ortega-Ribera, Anabel Fernández-Iglesias, et al.
Frontiers in Zoology|April 19, 2011
Mitigating amphibian disease: strategies to maintain wild populations and control chytridiomycosisDouglas C Woodhams, Jaime Bosch, Cheryl J Briggs, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2012
Patients whose first episode of bleeding occurs while taking a β-blocker have high long-term risks of rebleeding and deathAndrea Ribeiro de Souza, Vincenzo La Mura, Enric Reverter, et al.
Hepatology (Baltimore, Md.)|November 28, 2012
Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunctionVincenzo La Mura, Marcos Pasarín, Cintia Z Meireles, et al.
Journal of Gastroenterology|September 27, 2012
Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantationGonzalo Crespo, José A Carrión, Mairene Coto-Llerena, et al.
Pageof 37

Showing results (281-290 of 364) with videos related to

Sort By:
Pageof 37
Hepatology (Baltimore, Md.)|April 9, 2008
Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trialJaime Bosch, Dominique Thabut, Agustín Albillos, et al.
Hepatology (Baltimore, Md.)|November 26, 2002
Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosisRafael Bañares, Eduardo Moitinho, Ana Matilla, et al.
Hepatology (Baltimore, Md.)|December 21, 2016
Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet studyAnnalisa Berzigotti, Agustín Albillos, Candid Villanueva, et al.
The New England Journal of Medicine|June 25, 2010
Early use of TIPS in patients with cirrhosis and variceal bleedingJuan Carlos García-Pagán, Karel Caca, Christophe Bureau, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 15, 2013
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control studyFilippo Schepis, Ranka Vukotic, Annalisa Berzigotti, et al.
Clinical Science (London, England : 1979)|April 24, 2014
A novel form of the human manganese superoxide dismutase protects rat and human livers undergoing ischaemia and reperfusion injuryDiana Hide, Martí Ortega-Ribera, Anabel Fernández-Iglesias, et al.
Frontiers in Zoology|April 19, 2011
Mitigating amphibian disease: strategies to maintain wild populations and control chytridiomycosisDouglas C Woodhams, Jaime Bosch, Cheryl J Briggs, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2012
Patients whose first episode of bleeding occurs while taking a β-blocker have high long-term risks of rebleeding and deathAndrea Ribeiro de Souza, Vincenzo La Mura, Enric Reverter, et al.
Hepatology (Baltimore, Md.)|November 28, 2012
Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunctionVincenzo La Mura, Marcos Pasarín, Cintia Z Meireles, et al.
Journal of Gastroenterology|September 27, 2012
Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantationGonzalo Crespo, José A Carrión, Mairene Coto-Llerena, et al.
Pageof 37